Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPASS 2-AD: BFB759 in Atopic Dermatitis
NCT07105488Phase 2Active, not recruiting
- Start
- Jul 2025
- Primary completion
- Feb 2027
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of BFB759 in atopic dermatitis (AD). Started Jul 2025; status: active, not recruiting.
02
Drugs
BFB759
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07105488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07105488.